NDC 52959-026

Carisoprodol

Carisoprodol

Carisoprodol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by H.j. Harkins Company, Inc.. The primary component is Carisoprodol.

Product ID52959-026_8baadcf8-d2c4-40c6-9fa0-485a0d699745
NDC52959-026
Product TypeHuman Prescription Drug
Proprietary NameCarisoprodol
Generic NameCarisoprodol
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1996-01-24
Marketing CategoryANDA / ANDA
Application NumberANDA040124
Labeler NameH.J. Harkins Company, Inc.
Substance NameCARISOPRODOL
Active Ingredient Strength350 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
DEA ScheduleCIV
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 52959-026-56

56 TABLET in 1 BOTTLE, PLASTIC (52959-026-56)
Marketing Start Date1996-01-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52959-026-42 [52959002642]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-24 [52959002624]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-50 [52959002650]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-28 [52959002628]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-30 [52959002630]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-90 [52959002690]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-12 [52959002612]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-15 [52959002615]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-32 [52959002632]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-00 [52959002600]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-14 [52959002614]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-10 [52959002610]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-45 [52959002645]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-80 [52959002680]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-56 [52959002656]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-60 [52959002660]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-21 [52959002621]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-25 [52959002625]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-20 [52959002620]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-06 [52959002606]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-52 [52959002652]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-03 [52959002603]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

NDC 52959-026-40 [52959002640]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA040124
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-01-24
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
CARISOPRODOL350 mg/1

OpenFDA Data

SPL SET ID:037618dc-8aed-4a96-93a5-69971f2a3742
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197446

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Carisoprodol" or generic name "Carisoprodol"

    NDCBrand NameGeneric Name
    0143-1176CarisoprodolCarisoprodol
    0143-9749CarisoprodolCarisoprodol
    0591-5513CarisoprodolCarisoprodol
    0603-2582CarisoprodolCarisoprodol
    10544-033CarisoprodolCarisoprodol
    10544-088CARISOPRODOLCARISOPRODOL
    10544-132CarisoprodolCarisoprodol
    12634-437CarisoprodolCarisoprodol
    16571-780carisoprodolcarisoprodol
    16571-781carisoprodolcarisoprodol
    16714-510CarisoprodolCarisoprodol
    29033-207CarisoprodolCarisoprodol
    29033-214CarisoprodolCarisoprodol
    33261-387CarisoprodolCarisoprodol
    33358-064CARISOPRODOLCARISOPRODOL
    35356-721CarisoprodolCarisoprodol
    42254-068CarisoprodolCarisoprodol
    42543-434CARISOPRODOLCARISOPRODOL
    42543-700CARISOPRODOLCARISOPRODOL
    43063-302CarisoprodolCarisoprodol
    43063-824CarisoprodolCarisoprodol
    43353-102CARISOPRODOLCARISOPRODOL
    68071-2188CarisoprodolCarisoprodol
    68071-4263CarisoprodolCarisoprodol
    68071-4112CarisoprodolCarisoprodol
    68071-4610CARISOPRODOLCARISOPRODOL
    68387-600CarisoprodolCarisoprodol
    68788-6866CarisoprodolCarisoprodol
    68788-2582CarisoprodolCarisoprodol
    68788-9976CARISOPRODOLCARISOPRODOL
    70518-0704CarisoprodolCarisoprodol
    70518-1092CarisoprodolCarisoprodol
    70518-1401CarisoprodolCarisoprodol
    71335-0131CarisoprodolCarisoprodol
    71205-241CARISOPRODOLCARISOPRODOL
    71335-0407CarisoprodolCarisoprodol
    71335-0516CARISOPRODOLCARISOPRODOL
    71335-0693CARISOPRODOLCARISOPRODOL
    71610-097CARISOPRODOLCARISOPRODOL
    75921-513CARISOPRODOLCARISOPRODOL
    76333-135CarisoprodolCarisoprodol
    50090-0281CarisoprodolCarisoprodol
    49999-064CarisoprodolCarisoprodol
    50090-0280CarisoprodolCarisoprodol
    50090-2530CarisoprodolCarisoprodol
    50090-3232CarisoprodolCarisoprodol
    50090-3048CARISOPRODOLCARISOPRODOL
    50090-3211CarisoprodolCarisoprodol
    50090-2771CarisoprodolCarisoprodol
    50228-109CARISOPRODOLCARISOPRODOL
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.